Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias (Q38382105)

2 September 2017

Leukemia research in Germany: the Competence Network Acute and Chronic Leukemias (English)

1 reference

2 September 2017

0 references

15

1 reference

2 September 2017

10

Nicola Gökbuget

0 references

Hartmut Döhner

5

object named as

Hartmut Döhner

1 reference

2 September 2017

7

Gerhard Ehninger

1 reference

2 September 2017

3

Carlo Aul

1 reference

Aristoteles A N Giagounidis

2 September 2017

9

object named as

Aristoteles Giagounidis

1 reference

2 September 2017

17

Dietger Niederwieser

1 reference

2 September 2017

10

Nicola Gökbuget

1 reference

2 September 2017

11

Martin Griesshammer

1 reference

2 September 2017

19

Christoph Röllig

1 reference

2 September 2017

Ute Kossak-Roth

1

1 reference

2 September 2017

Susanne Saußele

2

1 reference

2 September 2017

Thomas Büchner

4

1 reference

2 September 2017

Martin Dugas

6

1 reference

2 September 2017

Arnold Ganser

8

1 reference

2 September 2017

Jörg Hasford

12

1 reference

2 September 2017

Michael Heuser

13

1 reference

2 September 2017

Wolfgang Hiddemann

14

1 reference

2 September 2017

Dieter Hoelzer

16

1 reference

2 September 2017

Andreas Reiter

18

1 reference

2 September 2017

Rüdiger Hehlmann

20

1 reference

2 September 2017

language of work or name

German

0 references

publication date

15 March 2016

1 reference

2 September 2017

Bundesgesundheitsblatt

1 reference

2 September 2017

59

1 reference

2 September 2017

4

1 reference

2 September 2017

444-453

1 reference

https://scigraph.springernature.com/pub.10.1007/s00103-016-2315-x

2 September 2017

0 references

cites work

[The competence network "acute and chronic leukemias"].

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

How I treat older patients with ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

21 January 2018

Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

How I treat CML blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Recommendations to meet statistical challenges arising from endpoints beyond overall survival in clinical trials on chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Establishment and validation of analytical reference panels for the standardization of quantitative BCR-ABL1 measurements on the international scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Standardized definitions of molecular response in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Harmonization of molecular monitoring of CML therapy in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

A unified definition of clinical resistance and intolerance to hydroxycarbamide in polycythaemia vera and primary myelofibrosis: results of a European LeukemiaNet (ELN) consensus process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM090

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

The German competence network ‘Acute and chronic leukemias’

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00103-016-2315-X

10.1007/S00103-016-2315-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference